Actions

Summary tables comparing neoplastic disorders: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 20: Line 20:
|-
|-
|colspan="1" style = "font-size:90%;" |'''CD5'''
|colspan="1" style = "font-size:90%;" |'''CD5'''
|colspan="1" style = "background:#004466;"|
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80
|colspan="1" style = "background:#004466;"|
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5%
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5%
|-
|-

Revision as of 17:41, 21 June 2023

Immunophenotype LPD
Marker CLL MCL FL
κ/λ 40:60 (wk) >80 60:80
FMC7 20:40 (wk)" 40:60 40:60
CD5 >80 >80 <5%
CD10
CD11C
CD19
CD20
CD23
CD25 wk
CD38
CD43
CD79a wk
CD103
CD138
CD200

Key to table:


Key to colour code Click for link

Key to expression code Click for link